XTX Topco’s Maravai LifeSciences MRVI Stock Holding History

XTX Topco’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.7M	Buy	433,231 +259,786	+150%	+$1.12M	0.04%	827
2026 Q1	$491K	Buy	173,445 +96,730	+126%	+$328K	0.01%	2071
2025 Q4	$249K	Sell	76,715 -35,754	-32%	-$120K	0.01%	2227
2025 Q3	$323K	Buy	+112,469	New	+$287K	0.02%	1453
2025 Q2	–	Sell	-99,458	Closed	-$220K	–	2880
2025 Q1	$220K	Buy	99,458 +61,270	+160%	+$242K	0.01%	1640
2024 Q4	$208K	Buy	38,188 +14,936	+64%	+$96.1K	0.02%	1528
2024 Q3	$193K	Buy	+23,252	New	+$201K	0.01%	1457
2024 Q2	–	Sell	-15,117	Closed	-$131K	–	2249
2024 Q1	$131K	Buy	+15,117	New	+$102K	0.02%	1295
2023 Q4	–	Sell	-24,615	Closed	-$246K	–	1913
2023 Q3	$246K	Buy	+24,615	New	+$270K	0.04%	873

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

XTX Topco's MRVI Position: Q2 2026 in Review

XTX Topco increased its Maravai LifeSciences (MRVI) stake by 150% in Q2 2026, buying an estimated $1.12M and bringing the position to 433,231 shares worth $2.7M. The position accounts for 0.04% of the portfolio, ranked #827.

XTX Topco first reported a position in MRVI in Q3 2023 and has held it in 9 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

XTX Topco held 433,231 shares of Maravai LifeSciences worth $2.7M as of Q2 2026.
XTX Topco bought 259,786 Maravai LifeSciences shares in Q2 2026, an estimated $1.12M.
Maravai LifeSciences made up 0.04% of XTX Topco's portfolio in Q2 2026, its #827 holding.
XTX Topco first reported a position in Maravai LifeSciences in Q3 2023 and has held it in 9 quarters since.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.